Robotic Sacrocolpopexy and Sacrocervicopexy - an Observational Study to Confirm the Peri- and Postoperative Safety and Clinical Performance

NCT ID: NCT07031050

Last Updated: 2025-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-19

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted sacrocolpopexy or sacrocervicopexy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sacrocolpopexy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sacrocolpopexy or sacrocervicopexy

Robotic-assisted sacrocolpopexy or sacrocervicopexy with the Dexter robotic surgery system

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \> 18 years
* Women with symptomatic stage I or greater pelvic organ prolapse (POP-Q)
* Patient agrees to perform the 6-week follow-up assessment as per Standard of Care

Exclusion Criteria

* Any planned non-urogynaecological concomitant procedures
* History of previous POP surgery, with the exception of transvaginal approaches without mesh implantation
* Previous surgery and/or radiation for urologic, gastrointestinal or gynecologic cancer
* History of Crohn's disease
* Chronic colitis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Confinis

INDUSTRY

Sponsor Role collaborator

Distalmotion SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status RECRUITING

Universitätsklinikum Bonn

Bonn, , Germany

Site Status NOT_YET_RECRUITING

Krankenhaus St. Elisabeth

Damme, , Germany

Site Status RECRUITING

Universitätsmedizin Essen

Essen, , Germany

Site Status NOT_YET_RECRUITING

Inselspital Bern

Bern, , Switzerland

Site Status RECRUITING

Spitäler FMI AG

Interlaken, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pascal Lehmann

Role: CONTACT

+41215105890

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jörg Neymeyer, MD

Role: primary

+4930450515272

Dominique Könsgen-Mustea, MD

Role: primary

+4922828715444

Bernd Holthaus, MD

Role: primary

+41549160360

Fabinshy Thangarajah, MD

Role: primary

+492017233570

Michael Müller, MD

Role: primary

+41316321203

Matthias Streich, MD

Role: primary

+41338262626

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Versius Gynecology Study
NCT07289295 RECRUITING NA